CollPlant Biotechnologies Ltd Selling, General and Administrative Expense
CollPlant Biotechnologies Ltd (CLGN) reported Selling, General and Administrative Expense of $3.66 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-01.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2020-04-01
- CollPlant Biotechnologies Ltd selling general and administrative expense for the quarter ending 2018-06-30 was 3.09M ILS, a 94.71% increase year-over-year.
- CollPlant Biotechnologies Ltd selling general and administrative expense for the quarter ending 2017-06-30 was 1.59M ILS.
ILS
| Period end | Selling General And Administrative Expense 3 month | Selling General And Administrative Expense 6 month | Selling General And Administrative Expense 12 month |
|---|---|---|---|
| 2018-12-31 | 12.48M ILS 20-F · filed 2019-04-01 | ||
| 2018-06-30 | 3.09M ILS 6-K · filed 2018-09-21 | 6.54M ILS 6-K · filed 2018-09-21 | |
| 2017-12-31 | 8.30M ILS 20-F · filed 2019-04-01 | ||
| 2017-06-30 | 1.59M ILS 6-K · filed 2018-09-21 | 2.93M ILS 6-K · filed 2018-09-21 | |
| 2016-12-31 | 11.05M ILS 20-F · filed 2019-04-01 | ||
| 2015-12-31 | 6.95M ILS 20-F · filed 2018-03-20 |
USD
| Period end | Selling General And Administrative Expense 3 month | Selling General And Administrative Expense 3 month as first filed | Selling General And Administrative Expense 6 month | Selling General And Administrative Expense 6 month as first filed | Selling General And Administrative Expense 12 month | Selling General And Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | $3.66M 20-F · filed 2020-04-01 | |||||
| 2019-06-30 | $944.00K 6-K · filed 2019-09-26 | $1.81M 6-K · filed 2019-09-26 | ||||
| 2018-12-31 | $3.72M 20-F · filed 2020-04-01 | $3.33M 20-F · filed 2019-04-01 | ||||
| 2018-06-30 | $863.00K 6-K · filed 2019-09-26 | $812.00K 6-K · filed 2018-09-21 | $1.86M 6-K · filed 2019-09-26 | $1.79M 6-K · filed 2018-09-21 | ||
| 2017-12-31 | $2.47M 20-F · filed 2020-04-01 | $2.39M 20-F · filed 2018-03-20 |